With more understanding of molecular mechanisms of carcinogenesis, novel molecular agents targeting epidermal growth factor receptor, vascular epithelial growth factor receptor, or c-Met has been proposed for the treatment of PAC [7, 8]. This evidence concerns the gene MET and gonorrhea.